Credit Suisse Multialternative Strategy Fund CERE Holdings History
Credit Suisse Multialternative Strategy Fund's Cerevel Therapeutics Holdings Inc Holding Summary
As of 2024-10-31, CREDIT SUISSE OPPORTUNITY FUNDS held - shares of Cerevel Therapeutics Holdings Inc(CERE), totaling N/A. This investment constitutes 0% of their stock portfolio, and CREDIT SUISSE OPPORTUNITY FUNDS now holds 0% of the outstanding Cerevel Therapeutics Holdings Inc(CERE) stock.
The initial trade took place in 2024Q1. And since then Credit Suisse Multialternative Strategy Fund has made 1 purchases of CERE, at an average price of $35.56, for a total of 21,015.00 shares. In addition, there have been 2 sales at an average price of $44.59 for 21,015.00 shares. Based on historical transaction data and CERE's current price of $44.96, Credit Suisse Multialternative Strategy Fund's estimated gain on his CERE holdings is $189,666.26, reflecting a 25.38% gain to date.
Credit Suisse Multialternative Strategy Fund CERE ($44.96) Holding Chart
Credit Suisse Multialternative Strategy Fund CERE ($44.96) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
